Agilon Health (AGL) Liabilities and Shareholders Equity (2020 - 2026)

Agilon Health (AGL) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $1.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 22.14% year-over-year to $1.5 billion; the trailing twelve-month figure through Mar 2026 stood at $6.1 billion (down 23.18% YoY), and the FY2025 full-year result was $1.3 billion, down 26.68% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $1.5 billion, up from $1.3 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $2.4 billion in Q2 2023 and bottomed at $1.3 billion in Q4 2025.
• The 5-year median for Liabilities and Shareholders Equity is $1.9 billion (2022), against an average of $1.9 billion.
• The widest annual swing landed in 2022, when Liabilities and Shareholders Equity surged 223.19%; it then retreated 26.68% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.7 billion in 2022, then increased by 2.56% to $1.7 billion in 2023, then declined by 0.4% to $1.7 billion in 2024, then dropped by 26.68% to $1.3 billion in 2025, then advanced by 18.38% to $1.5 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $1.5 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.

Peer Comparison